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Abstract
Obstructive sleep apnea continues to be an area that is underdiagnosed and therefore
undertreated. Left untreated, the condition is associated with increased morbidity and mortality
as it can amplify the risk of multiple health conditions. Due to the negative impact of obstructive
sleep apnea it is necessary for healthcare providers to provide timely detection. Primary care
providers are in a position to identify high-risk individuals and refer them for further follow up
testing. High-risk identification can be accomplished by integrating validated screening tools into
patient assessments. This integrative review provides an overview of current screening tools for
use in the primary care setting, barriers to screening adoption, and successful practices.
Keywords: obstructive sleep apnea, primary care, screening tools
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Introduction
Sleep disorders are common in the United States, yet data supports that primary care
providers (PCP) do not routinely ask about sleep health (Grandner & Malhotra, 2015).
Obstructive sleep apnea (OSA) is an aspect of sleep health that is grossly under detected
(American Sleep Apnea Association , 2019). It is a major concern due to the myriad of health
risks associated with the disorder. A review of current literature is timely to identify strategies
that can bridge the gap between known under detection and appropriate treatment.
Background
Obstructive Sleep Apnea
Obstructive sleep apnea is a disorder defined by pauses in breathing patterns secondary to
muscle relaxation, and soft tissue being able to block portions of the upper airway (Harvard
Medical School, 2011). The collapse of tissue in the pharynx slows or even stops inspiration and
expiration. A drop in the oxygen level in the blood signals the brain to facilitate a brief
interruption to the sleep cycle in order to resume breathing (American Lung Association, 2019;
Mayo Clinic, 2019). Apnea can happen frequently during sleeping without an individual being
aware (American Lung Association, 2019).
OSA is different from central sleep apnea, as the pharynx is blocked due to a relaxation
of muscles in the pharynx rather than a problem originating from a lack of signaling from the
brain (NIH, 2018). The main types of sleep apnea consist of OSA, central sleep apnea, and a
combination of obstructive and central apnea. The most common form of sleep apnea is OSA
(Mayo Clinic, 2019). Symptoms associated with OSA include snoring, daytime sleeping, pauses
in breathing, difficulties with memory and concentration, unusual moodiness or irritably,
frequently waking up to urinate at night, morning headaches, and dry mouth (American Lung

Association, 2019). There are several identified risk factors associated with OSA. Some of these
are preventable and include lifestyle habits and environment, whereas other risk factors based on
age, family history, genetics, race, and sex are non-preventable (NIH, 2018).
Obesity is one of the biggest risk factors for OSA, with more than 50% of the diagnoses
being linked to overweight individuals. This is attributed to an increased tissue deposit around
the neck. Ethnic groups such as African Americans, Hispanics, and Native Americans are
disproportionally impacted by the disease, which is likely due to the proportion of obesity in
these populations (Dudley & Patel, 2016). Age is another one of the major risk factors. While
sleep apnea can occur at any age, there is a strong correlation with sleep apnea and aging
individuals. The USPTF and AASM specifically note that those aged 40-70 are considered at
increased risk for the OSA (Bibbins-Domingo et al., 2017; Semelka et al., 2016). Furthermore,
individuals under the age of 70 with OSA are noted to be at an increased risk of premature death
(Franklin & Lindberg, 2015).
Obstructive Sleep Apnea Questionnaires
The increasing prevalence of OSA and the underdiagnosis of the condition support the
need for an effective screening method (American Sleep Apnea Association, 2019; El-Sayed,
2012). The Berlin, STOP, STOP-Bang, and Epworth Sleep Study questionnaires are four
screening tools that are commonly utilized to identify OSA. They have been tested in various
practice settings. These tools utilize questions based on common signs and symptoms associated
with OSA (El-Sayed, 2012).
Berlin Questionnaire
The Berlin Questionnaire was developed in 1996 at a primary care conference based in
Berlin, Germany by a group of primary and respiratory physicians (Tan et al., 2017). This

questionnaire was developed specifically for identifying OSA in primary care but does have
some utility in non-primary care settings (El-Sayed, 2012). It is a questionnaire that stratifies
individuals into high-or low-risk groups. The questionnaire asks a total of 10 questions along
with information on patient demographics such as age, gender, height, and weight. The questions
address common signs and symptoms that can be associated with sleep apnea such as snoring,
daytime fatigue, obesity, and hypertension (Tan et al., 2017). Scoring for the questionnaire is
based on three categories with high-risk exhibiting positive findings for two or more of the
categories (American Sleep Apnea Association, n.d.).
STOP and STOP-Bang Questionnaire
The STOP and STOP-Bang Questionnaires were first developed in 2008 for their utility
in screening surgical patients (El-Sayed, 2012). The STOP and STOP-Bang utilize four and eight
dichotomous questions respectively and can be completed quickly. While developed for the presurgical community they have also be utilized and validated in several other patient populations
(Chung et al., 2016). The STOP-Bang utilizes questions from (STOP) snoring, tiredness,
observed apnea, and high blood pressure along with demographic information. The Bang portion
of the questionnaire includes information regarding body mass index (BMI), age, neck
circumference, and gender (Chung et al., 2016).
Epworth
The Epworth Sleepiness Scale was developed in 1991 and is another common tool that
can be utilized to screen for sleep apnea since sleepiness is one of the common symptoms
associated with OSA. However, this tool only provides a subjective assessment of daytime
sleepiness and does not include some of the other symptoms that can be associated with OSA. It

is important to note that not all patients with OSA present with daytime sleepiness (Omobomi &
Quan, 2018).
Problem Statement
OSA is a growing concern within the United States as there are an estimated 22 million
Americans that suffer from the condition. The national average for the condition is postulated to
range between 2-10% of the adult population (Miles et al., 2017). Additionally, data supports
that 80% of moderate to severe obstructive sleep apnea remains undiagnosed (American Sleep
Apnea Association , 2019). There is a strong correlation of OSA among obese populations, and
in western society the prevalence of OSA is speculated to increase (Garvey et al., 2015).
It is important to note that the general public does not routinely recognize symptoms or
associated severity with OSA (Frost & Sullivan, 2016). Another identified barrier is that primary
care providers do not routinely ask patients questions related to sleep quality or duration (Frost &
Sullivan, 2016). Providers may not investigate an early OSA diagnosis if the patient does not
present with a complaint of fatigue or classic high body mass index (BMI). This can be further
complicated since fatigue can also be credited to existing comorbidities. However, evidence
supports that lack of fatigue does not rule out sleep breathing disorders and as much as 50% of
individuals with OSA are not obese (Osman et al., 2018).
Economic
The health risks associated with untreated sleep apnea can also have noteworthy
economic consequences as the AASM estimates that undiagnosed OSA cost the United States
$149.6 billion dollars in 2015 alone (Frost & Sullivan, 2016). The economic strain of the chronic
condition impacts not only the nation, but individuals as well. Direct costs of obstructive sleep
apnea are associated with co-morbidities, workplace injuries, and car accidents. Meanwhile,

indirect costs associated with OSA may include reduced productivity, quality of life, and strain
on relationships (Frost & Sullivan, 2016).
Co-Morbidities & Complications
Sleep apnea is a significant problem since untreated sleep apnea can increase risks
associated with asthma, some cancers, hypertension, arrhythmias, heart disease, chronic kidney
disease, cognitive and behavioral disorders, eye disorders, stroke, diabetes, pregnancy
complications, and premature death (Knauert et al., 2015; NIH, 2018).
Asthma
It is noted that patients with asthma have a greater chance of OSA when compared to the
general population, with OSA potentially worsening asthma-related outcomes. Evidence
supports that asthma patients with OSA have a higher association with poor asthma control,
increased nocturnal symptoms, and recurrent exacerbations. While there is a link between asthma
and OSA the exact mechanics behind the process remain hypothetical, but OSA has been
associated with airway remodeling due to inflammation. Patients with OSA and asthma that are
treated with a CPAP seem to have improvement of symptoms as evidenced by peak flow
readings and reported quality of life (Dixit, 2018).
Cancer
Obstructive sleep apnea has also been associated with an increased risk of cancer
mortality. A Wisconsin sleep cohort study published by Nieto et al. (2012) demonstrated an
increase in mortality among cancer patients with severe sleep breathing disorders compared to
those without. The association between cancer mortality and sleep breathing disturbances
remained high even after accounting for variables such as “age, sex, smoking, BMI, physical
activity, diabetes, weight circumference, and sleep duration” (National Sleep Foundation, 2019;

Nieto et al., 2012, p. 192). While there is a correlation, there is not a clear understanding of
whether OSA contributes to the formation of cancer or mainly facilitates its growth. However,
animal studies demonstrate that intermittent hypoxia promotes angiogenesis and tumor growth
(National Sleep Foundation, 2019).
Hypertension
Multiple studies and papers have been dedicated to demonstrating the link of obstructive
sleep apnea with resistant hypertension. Resistant hypertension is characterized as elevated blood
pressure that elicits a poor response to treatment requiring multiple medications (Yaxley &
Thambar, 2015). There are several proposed theories regarding the pathology behind severe OSA
and resistant hypertension. Severe OSA has correlated with poor blood pressure control and
increased cardiovascular risk. CPAP therapy may provide benefits by reducing blood pressure
and overall cardiovascular disease risk (Harding, 2014).
Arrhythmias
Several arrhythmias have been associated with obstructive sleep apnea. Atrial fibrillation
is a common arrhythmia encountered in patients with OSA. The exact pathophysiology behind
the development of arrhythmias in individuals with OSA remains unclear, but there are a few
hypotheses that have been suggested. A hypothesis is that reduced blood oxygen saturation and
increased carbon dioxide levels cause complications in both the chemoreflex and baroreflex
functions (Patel et al., 2019). This could lead to an activation of the sympathetic system and
electrical remodeling within the heart. Another proposed hypothesis is that hypertension that
often coincided with OSA, is linked to the development of atrial fibrillation. Evidence supports
that hypertension can cause atrial remodeling. Continuous positive airway pressure (CPAP) has

shown to be effective in the treatment of OSA and has the benefit of reducing the incidence of
arrhythmia in OSA patients (Patel et al., 2019).
Chronic Kidney Disease
Obstructive sleep apnea has a causal link with chronic kidney disease (CKD) due to the
association with chronic hypertension. OSA, through the cycling of sleep fragmentation and
arousals, contributes to the progression by increasing sympathetic nerve discharge, reninangiotensin-aldosterone system (RAAS) activation and increased vascular resistance. Studies on
OSA have been associated with glomerular hyperfiltration and glomerular sclerosis (Adeseun &
Rosas, 2010). Data suggests that there is a bidirectional relationship between OSA and CKD
with OSA contributing to the progression of CKD and CKD worsening the risk associated with
OSA (Abuyassin et al., 2015).
Memory and Behavioral Disorders
Several studies have demonstrated that cognitive impairment is a complication associated
with OSA. Deficits in executive functioning, memory, and attention are one of the negative
consequences of the disorder. Executive function includes the ability to reason, perform tasks,
plan, and engage in problem solving. Obstructive sleep apnea is not exclusive to the adult
population and can be seen all ages. Furthermore, cognitive disfunction linked with the OSA has
been observed in children as well as adults (Krysta et al., 2017). The exact prevalence of
cognitive dysfunction associated with OSA is unknown as there is large variation within studies.
Variations such as heterogenicity of the sample, premorbid IQ, education level of the subjects,
oxygen levels, selection of a comparison group, and even continuity in memory tasks are
important to note. Combination studies of neurophysiological and neuroimaging have helped to
further support the link of cognitive decline in patients with OSA (Krysta et al., 2017).

Eye Disorders
Obstructive sleep apnea is associated with several ophthalmic conditions. Floppy eye
syndrome, glaucoma, and nonarterial anterior ischemic optic neuropathy are some of the
conditions that appear to have a link with OSA. Due to the increased risk of eye disorders in
patients with OSA it is important that physicians are aware and refer patients to obtain
ophthalmic evaluation and any necessary treatment (Skorin & Knutson, 2016).
Stroke
Obstructive sleep apnea is an independent risk factor for stroke patients. Left untreated,
OSA in stroke patients could lead to a recurrent stroke. It is also to be noted that OSA has a
bidirectional relationship with severity of the stroke manifestations and the degree of recovery
after a stroke. CPAP therapy has proven beneficial in improving cognitive and overall function
among stroke patients with OSA (Jehan et al., 2018).
Diabetes
The association of OSA and type II diabetes are suggested to be independent of agerelated changes or obesity (Muraki et al., 2018). Furthermore, OSA is noted as a co-morbidity of
diabetes due to the increased prevalence in the diabetic population and nearly half of type II
diabetics suffering with OSA. The association of decreased insulin sensitivity and OSA has been
demonstrated through animal studies with intermittent hypoxia. It is believed that the
sympathetic pathway is activated by the intermittent hypoxia resulting in oxidative stress and
systemic inflammation that subsequently cause changes in hormonal balance (Muraki et al.,
2018).

Pregnancy Complications
While sleep apnea is relatively low among women of reproductive age. It is important to
note that pregnancy does increase risk of sleep disordered breathing (SDB). While the exact
cause is not well understood “the physiological hormonal, mechanical, and cardiovascular
changes of pregnancy may place women at risk of developing SDB or exacerbate existing sleep
disorders” (Izci, 2015, p. 270). Higher levels of estrogen, progesterone, and other hormones may
play a significant role in the anatomical narrowing and resistance due to capillary engorgement,
hypertension, and edema (Izci, 2015).
Premature Death
A large sleep study that was conducted for over 18 years indicated that patients with
severe sleep apnea have a mortality rate that is approximately three times greater than individuals
without apnea (UWHealth, 2016; Young et al., 2008). This study consisted of a randomized
sample of men and women (n= 1,522) within the community between the ages of 30 and 60 at
the start of the study. Findings of the study indicated a high all-cause mortality risk with severe
sleep breathing disorders even when adjusted for age, sex, and BMI. This study highlights the
importance of clinical recognition and treatment of SBD (Young et al., 2008). Furthermore, the
Wisconsin Sleep Cohort supports that continuous positive air pressure therapy (CPAP) does
reduce overall mortality (AASM, 2008).
Purpose of the Project
The scholarly project's purpose was to seek improvement in healthcare screening
practices for OSA in primary care settings by the identification of best screening tools for the
PCP, detection of barriers, and strategies to increase OSA screening. These goals were developed
as there continues to be gap between the known under detection and lack of routine questions

regarding sleep health in primary care (Grandner & Malhotra, 2015). This project initiative
correlated with the American Academy of Sleep Medicine’s suggestion to screen individuals that
are considered high-risk based on risk factors (AASM, 2017).
Clinical Question
This review of the literature sought to answer clinical questions to improve detection and
standardization of OSA screening in primary care. The clinical questions aimed to promote
timely identification of sleep apnea risk for patients that could be used to determine a need for
further follow-up testing. Additionally, the review considered best methods to integrate sleep
apnea screening into primary care to promote sustainability. Three clinical questions guided the
integrative review of the literature and provided a broad scope of the current facilitators and
barriers to OSA screening by primary care providers.
Project Goals
1.) What valid and reliable OSA questionnaires, for the adult population, have the best
utility in the primary care setting?
2.) What are perceived barriers among health professionals in utilizing OSA screening
questionnaires in primary care?
3.) What practices have been successful in increasing OSA screenings for high risk
patients?
Methods
Protocol and Framework
Integrative reviews are described as a review of the available research and should uphold
a standard in methodology (Whittemore & Knafl, 2005). “The integrative review method can
incorporate diverse methodologies in order to capture the context, processes, and subjective

elements of the topic” (Whittemore & Knafl, 2005, p. 552). Robust integrative reviews have the
potential to advise further research, policy, and practice initiatives. While this method can
provide a holistic view on an issue the combination of different study types can make this
process a challenge (Whittemore & Knafl, 2005). Utilization of a framework in the integrative
review process facilitates systematic practices and sets a standard for academic excellence. The
OSA integrative review utilizes the Preferred Reporting Items for Systematic Review and MetaAnalyses (PRISMA) framework as a means to safeguard quality.
The PRISMA framework was developed during 1996 in response to an identified need
for improved the reporting quality of meta-analyses (Moher et al., 2009). This framework
utilized a 27-point checklist along with a four-phase flow diagram (Moher et al., 2009). The
PRISMA checklist was utilized to outline the paper with seven main headings and multiple subheadings. The four-phase diagram was also utilized to map the systematic approach of collecting
scholarly articles for the integrative review. The PRISMA flow diagram methodology is
embraced as it guides the reviewer in carefully formulating a question, meticulously identifying
articles, screening, and inclusion of literature in the integrative review (Moher et al., 2009;
Whittemore & Knafl, 2005). The integrative review method with PRISMA is further
characterized by an analysis of studies included with or without statistical scrutiny (Moher et al.,
2009). Whittemore and Knafl (2005) supplemented the PRISMA checklist and flow diagram by
offering further suggestions in the data analysis stage through data reduction, data display, data
comparison, conclusions and verification.
Eligibility Criteria
Inclusion criteria for the integrative review, on the topic of obstructive sleep apnea,
included articles that were published in or after 2016 and in the English language. Clinical

questions helped to narrow the search further to those looking at questionnaire use in the primary
care setting for the adult population. References were not limited to the United States and
included studies conducted around the world. Exclusion criteria for journal articles and reports
comprised those published before 2016 as well as those that were published in a foreign
language. References with questionnaire use in the hospital, specialty practices, or with children
were also excluded from the search.
Information Sources
Liberty University’s online library was utilized to search clinical databases for scholarly
and relevant sources. Both ProQuest Medline and ProQuest: Nursing and Allied Health
Databases were utilized in the integrative review as these databases contain a wealth of scholarly
sources focused in health and medicine. Resources within these databases were carefully
reviewed for literature that was peer reviewed. DNP dissertations and scholarly projects were
also included in the review to increase evaluation on the topic of OSA screening. The PRISMA
flow diagram facilitated a systematic approach to obtaining and documenting sources based on
the inclusion and exclusion criteria. These databases and the approach guided by PRISMA
provided a means to review current literature for questionnaire utility in the primary care setting,
perceived provider barriers, and strategies that have proved beneficial in increasing OSA
screening.
Search
Since an integrative review is not meant to simply be a list of the current and available
literature, there is a process that should be utilized to standardize how literature is obtained and
reviewed. An expansive literature search was conducted utilizing ProQuest Medline and
ProQuest Nursing and Allied Health. Databases, such as the ones reviewed, are gateways to

rendering a body of evidence (Melnyk & Fineout-Overholt, 2019). A keyword search was
conducted in both of these large databases. Key words that were used in the search included
sleep apnea, obstructive sleep apnea, primary care, questionnaire, and adult. Literature that met
inclusion criteria was saved and then appraised based on Melnyk’s hierarchy of evidence
(Melnyk & Fineout-Overholt, 2011).
Of the 15 total articles systematically obtained, 13 were primary sources with the
remaining coming from secondary sources. Melnyk’s hierarch of evidence assessed the strength
of the articles included for merit in directing clinical practice. A range of evidence was identified
for the articles found that met both the inclusion and exclusion criteria. Two articles included in
the integrative review consisted of systematic reviews (level II) which are defined as including at
least one randomized control trial. One study included a quasi-experimental approach classified
as a level III in terms of evidence. Ten studies included in the review consisted of case control or
cohort studies and ranked as a level IV in evidence quality. A qualitative study was also included
and provided level VI evidence (University of Michigan, 2020).
Study Selection
The integrative review (IR) of literature was conducted to identify current best practices
for OSA screening in the primary care setting. Liberty University Institutional Review Board
(IRB) approval for the IR scholarly project was requested and obtained in accordance with
university standards. Following the PRISMA flow diagram with inclusion and exclusion criteria
provided 15 applicable journal articles. The 15 articles were extracted from the total 893 articles
after completing a key word search for articles published after 2015 using the two ProQuest
databases.

Data Collection Process
A search for available literature was done by utilizing Liberty’s online library. Medical
databases were chosen and included both ProQuest Medline and ProQuest: Nursing and Allied
Health to discover relevant articles on the topic of OSA screening tools in primary care. There is
a significant amount of literature available for OSA and screening tools. However, this particular
search was limited to studies with a focus on the primary care role in the discovery and treatment
of the OSA disorder utilizing screening tools. Studies were also limited to those that were
published within the last five years to provide current evidence.
Data Items
Selection of available articles found through the two ProQuest databases was a rigorous
process done to narrow down to the specific data items that addressed the clinical questions.
Reduction of the vast number of articles, available through the key word search, was done
systematically and the PRISMA model served as a guide for inclusion of relevant articles.
Eligible full text articles were read, and data was sifted through based on the subject and setting
of the study. Organization of the data items was achieved through the PRISMA flow diagram
and synthesis chart of eligible articles.
Risk for Bias in Individual Studies
Integrative and systematic reviews require consistency in the approach of identifying,
reviewing, and synthesizing articles to provide current evidence on clinical enquiries. Following
the PRISMA checklist and flow diagram helped to reduce bias as the writer documented the
approach and included all relevant literature on the topic of interest rather than just selecting
articles that supported a particular approach. The organized review of literature can help

healthcare leaders recognize the broad scope on an issue and make well informed decisions that
impact services provided (Liberati et al., 2009).
Summary Measures
The purpose of the integrative review was to answer the clinical questions of OSA
questionnaire utilization in the primary care setting. Finding tools with the best utility,
identification of barriers, and recognizing facilitators was accomplished and charted in a
literature results matrix. This matrix provides an overview of the applicable articles found by
including the focus of the article, level of evidence, background, practice implications and
recommendations.
Synthesis of Results
Literature notes a continued lack of OSA diagnosis and treatment which prompted a
review of current literature for primary care strategies in addressing the continued under
identification and treatment. Several OSA screening tools were identified during the literature
review to aid providers in discovery of high-risk signs and symptoms among patients. A few
barriers to screening tool adoption along with recommendations for practice were included to
improve the process of screening tool utilization in clinical practice.
Results
Study Selection
The review of literature rendered a total of 893 articles using two ProQuest databases
with keyword search and limiting articles to those published after 2015. The PRISMA flow
diagram was utilized to navigate the selection of applicable articles. The diagram provided a top
down approach for mapping the inclusion of articles. Identification, screening, eligibility, and
inclusion represented the steps to systematically reviewing scholarly sources. The flow chart first

displayed the total number of articles identified with each database and include ProQuest
Medline (641) and ProQuest: Nursing and Allied Health (252). After duplicates from the two
databases were removed a total of 461 articles were available for screening. Of these articles,
420 were excluded for not meeting both the inclusion and exclusion criteria. The remining 55
articles were reviewed for eligibility based on relevance to the clinical questions. Based on the
clinical question, one qualitative and 14 quantitative articles were included in the integrative
review (See Appendix A).
Study Characteristics
A results matrix table was utilized to summarize the findings and appraise the evidence.
Including both qualitative and quantitative articles is one of the benefits of conducting an
integrative review. The methods of conducting an integrative review allowed for articles with
mixed methodologies such as experimental and non-experimental research that provided a robust
examination of available evidence (Whittemore & Knafl, 2005). Three clinical questions guided
the search for relevant articles to address the validity of screening tools, perceived barriers, or
successful practices in increasing screening practices within the primary care. No identifiable
bias was noted within or across the articles included in the review.
Synthesis of Results
Whittemore and Knafl (2005) detailed the data analysis process for an integrative review
and noted that there are four distinct parts to a detailed synthesis. The analysis advances through
data reduction, data display, data comparison, conclusions drawn and verification. This
systematic process helps to mitigate formulating premature conclusions (Whittemore & Knafl,
2005).

Data Reduction
The data reduction phase describes the classification and sub-categorization of articles.
This process can account for articles based on the chronology, setting, sample characteristics, or
other predetermined conceptual classification (Whittemore & Knafl, 2005). Data was reduced
using inclusion and exclusion criteria and further dwindled down based on the topics that
answered the preformulated clinical questions.
Data Display
The next step to data analysis included displaying the themes from the multiple sources.
Whittemore and Knafl (2005) stated that the data may be displayed using various forms such as
matrices, graphs, charts, or networks to provide a clear comparison across sources. Displaying
data in one or multiple forms helps to improve visualization for further interpretation. The
literature matrix table was developed to sort data by providing the level of evidence, background,
and conclusions for each article.
Data Comparison
Data comparison was then completed after finalizing the literature matrix table. Articles
that corresponded with the clinical questions were sorted and reviewed. The matrix table proved
beneficial in the process of comparing and contrasting the themes of reliable OSA
questionnaires, perceived barriers, and successful practices.
Conclusions Drawn and Verification
After a careful review of the available articles, conclusions were drawn and identified in
the summary of evidence. The review of available screening tools, barriers, and successful
practices provided a comprehensive depiction of the evidence. Generalities emerged from the

available articles to provide recommendations for integration into clinical practice through policy
changes or suggestions for further study.
Additional Analysis
Valid and Reliable OSA Questionnaires
The review of literature revealed a total of seven different screening tools that have been
tested in the primary care setting. The sensitivity and specificity data of the screening tools
depended largely upon the population screened as well as the data apnea-hypopnea index (AHI)
set point. The AHI notes the severity of sleep apnea and results can be classified as normal (0-5)
sleep, mild apnea (5-15), moderate apnea (15-30), or severe apnea (>30) (Miller & Berger,
2016). While some of the studies offered sensitivity and specificity data on all severity cutoffs
others offered sensitivity and specificity data only on a single AHI cutoff such as moderate apnea
(Miller & Berger, 2016). The STOP-Bang was by far the most utilized tool within the articles
reviewed. The Berlin Questionnaire and Epworth Sleepiness Scale both tied for the second most
common tools used within the available literature. Literature supports that the Berlin and STOPBang currently offer the best measures for the presence of moderate and severe apnea (Miller &
Berger, 2016). Use of the Epworth as an initial screening tool for OSA is cautioned due to
inconsistency with both sensitivity and specificity (Aurora & Quan, 2016; Miller & Berger,
2016).
STOP and STOP-Bang. The STOP-Bang was identified in nine of the articles included
in the review. Some provided data on the utility of this screening tool in the primary care setting,
whereas other articles looked at the process of implementing the questionnaire in the clinical
practice. The STOP questionnaire is a precursor to the STOP-Bang and was only reviewed in one
of the articles (Miller & Berger, 2016). While the STOP and STOP-Bang screening tools were

initially designed for the pre-surgical population, the STOP-Bang was readily used in the articles
reviewing the primary care setting due to the high sensitivity data and ease of use (Miller &
Berger, 2016).
A study that compared the STOP-Bang against the Berlin Questionnaire within the
diabetic population found the STOP-Bang had the highest sensitivity (87.2) for mild apnea but
was nonspecific to OSA. The STOP-Bang along with the Berlin has even better sensitivity with
moderate and severe apnea. Sensitivity improved but was still poor with moderate and severe
sleep apnea for both the STOP-Bang and Berlin (Edmonds et al., 2019). Another study reviewed
the utility of the STOP-Bang with patients suspect to have a sleep disorder and referred by their
primary care providers for a sleep study. The STOP-Bang used with individuals suspected to
have a sleep disorder provided a 98.62% sensitivity and 33.33% specificity (Rebelo-Marques et
al., 2018).
Berlin. The Berlin Questionnaire was implemented in four of the journal articles. This
questionnaire consistently had lower sensitivity than the STOP-Bang but offered an
improvement in specificity (Edmonds et al., 2019; Senaratna, 2019). As previously noted, a
literature review looking at Epworth, Berlin, and STOP-Bang screening questionnaires
highlighted that the Berlin and STOP-Bang currently offer the best questionnaire for OSA in the
primary care setting (Miller & Berger, 2016).
Epworth. Studies recommended against the use of the Epworth Sleepiness Scale (ESS)
as an initial screening of OSA due to lack of consistency with sensitivity and specificity data
(Aurora & Quan, 2016; Grover et al., 2016; Miller & Berger, 2016). Another study reviewed the
ESS in conjunction with the Berlin, STOP-Bang, and OSA-50 to determine how it would impact
predictive values. The ESS helped to raise the specificity from 21%-59% to 92-95% when used

with all three tools but also lowered the sensitivity from 65%-86% to 36%-51% (Senaratna,
2019).
Phillips. Data on the Phillips questionnaire was limited to a single article that reviewed
its function when used with overnight oximetry (Fabius et al., 2019). The study was able to
optimize cutoffs for the oximetry data index (ODI) and questionnaire based on results from
patients referred for sleep studies. A sensitivity of 99% and specificity of 65% was achieved
utilizing a two-step screening method using both the Phillips questionnaire and oximetry. Using
the two-step method improved sensitivity results beyond using oximetry data alone (Fabius et al.,
2019).
OSA 50. The OSA 50 screening tool was included in an article that cross analyzed the
sensitivity and specificity with the STOP-Bang & Berlin alone and in combination with the
Epworth Sleepiness Scale for moderate OSA. The OSA 50 provided moderate sensitivity (86%)
but low specificity (21%). Specificity (92%) for this tool improved when used with the ESS but
sensitivity (51%) data was impacted. The OSA 50, when compared against the other tools
provided the highest sensitivity but the lowest specificity (Senaratna, 2019).
SACS tool. The SACS tool was used in only one of the articles reviewed. This tool was
provided to a convenient sample of patients within the primary care setting with clinical
suspicion of sleep apnea. It is important to note that the study classified OSA as an AHI>10.
The SACS provided a sensitivity (44%) and specificity (89%) for moderate sleep apnea
(AHI>15). (Grover et al., 2016).
Perceived Barriers
Reviewing perceived screening barriers is important since there is a lack of utilization of
OSA questionnaires within the primary care setting (Bakhai et al., 2017; Devaraj, 2020; Khan et

al., 2019). Several articles addressed some of the perceived barriers to OSA screening in the
primary care setting. Five main themes emerged with the review of included articles. Studies
determined that inconsistency with practice guidelines, lack of awareness regarding available
screening tools, current screening test predictive values, time constraints, and electronic medical
record (EMR) limitations (Aurora & Quan, 2016; Bakhai et al., 2017; Khan et al., 2019;
Kleisiaris et al., 2016; Ononye et al., 2019).
Inconsistency with Guidelines. Screening guidelines vary across professional
organizations. The United States Preventative Services Task Force (USPSTF) position does not
recommend OSA screening in the general population whereas the American College of
Physicians’ guideline recommends screening individuals with symptoms such as unexplained
fatigue. The American Academy of Sleep Medicine recommends screening all high-risk
individuals such as those with atrial fibrillation (AF), obesity, hypertension, heart failure, stroke,
diabetes, and pulmonary hypertension (Khan et al., 2019). The lack of consistency across
guidelines makes it challenging to know what organizational recommendations to follow.
Time Constraints & Low Reimbursement Rates. Limitations on available time to
conduct screening questionnaires in the office was another barrier noted (Bakhai et al., 2017). A
quality improvement study performed a root cause study to evaluate patient, physician, and
material barriers to adoption of OSA screening. The extra time needed to complete the screening
forms was one of the physician barriers listed (Bakhai et al., 2017). Furthermore, low
reimbursement rates were an identified barrier that made screening for OSA less of a priority in
busy practice settings (Addogoh, 2018).

Lack of Awareness. A review of perceived barriers was done in a quality improvement
study and noted that one of the challenges was a lack of awareness of available screening tools as
well as education on appropriate sleep screening (Khan et al., 2019). This finding was supported
by several other articles (Bakhai et al., 2017; Miller & Berger, 2016). Furthermore, primary care
providers need to be educated on what high-risk groups and symptoms require further follow up
(Ononye et al., 2019; Kleisiaris et al., 2016).
Screening Test Predictive Values. Lack of assessment may also be linked to screening
tests failing to provide a combination of high sensitivity and high specificity (Miller & Berger,
2016). Most OSA screening tools provide high sensitivity but low-to-moderate specificity.
However, multiple articles conclude that there needs to be routine screening for OSA in the
primary care setting (Aurora & Quan, 2016; Kleisiaris et al., 2016; Miller & Berger, 2016;
Showalter & OʼKeefe, 2019).
Electronic Medical Record Limitations. An additional shortfall to OSA screening
identified in the literature search pointed to limits within the electronic medical records (Bakhai
et al., 2017). For practices that have OSA screening tools available in the EMR it is important to
note the extra steps of manual calculation and documentation added to a clinical workflow
(Bakhai et al., 2017). The absence of an automated algorithm and clinical decision support was
recognized as the greatest barrier to a quality improvement process aimed at increasing detection
and referral of high risk OSA patients (Bakhai et al., 2017).
Successful Practices
Review of successful practices to increasing OSA screening for high risk patients was
another aspect of the literature review. Three main themes emerged in regard to helpful

interventions for primary care practices. These themes include staff education, development of
an OSA screening protocol, and EMR improvements.
Staff Education. As noted earlier, lack of education or awareness on available screening
tools was one of the perceived barriers to OSA screening. Several studies noted that primary care
providers would likely benefit from further training on detection of OSA and impact of untreated
OSA (Devaraj, 2020; Khan et al., 2019; Miller & Berger, 2016). However, training should not be
limited to practitioners and should also include other key clinical personnel such as medical
office assistances, nurses, and clinic administrators. Education on OSA screening includes how
to administer as well as the value and potential benefit of routine OSA screening (Aurora &
Quan, 2016). Implementing an OSA screening training program has proven successful in
improving screening and referral rates for high risk patients within the primary care setting
(Addogoh, 2018).
OSA Screening Protocol. Another identified strategy for improving screening within the
primary care is to provide a screening protocol within the practice setting (Addogoh, 2018;
Ononye et al., 2019; Miller & Berger, 2016; Showalter & OʼKeefe, 2019). Several of the
screening protocols proved successful in identifying OSA high-risk patients that had not been
previously identified. Despite the recommendation to create a screening protocol for OSA there
were inconsistencies with what groups were screened and with what screening tool. In line with a
screening protocol was a recommendation to provide the screening tool to high-risk patients
prior to clinic visits (Aurora & Quan, 2016). Implementing a protocol that allows for completion
of the screening tool prior to the clinical visit can help improve workflow and mitigate time
restraints (Aurora & Quan, 2016).

Electronic Medical Record. The third main theme for improving success with OSA
detection and screening suggests the use of an electronic medical record. Several studies were
limited in the extent of being able to utilize the EMR, but suggested built-in alerts and reminders
through clinical support tools, integration of the screening tool in the EMR, and hard stops to
complete screening tools for at risk patients (Addogoh, 2018; Aurora & Quan, 2016; Grover et
al., 2016; Johnson, 2019; Miller & Berger, 2016; Senaratna, 2019; Showalter & OʼKeefe, 2019).
Integrating the screening tool in the EMR can help to streamline the process by reducing the time
healthcare providers are spending to manually entering OSA screening questionnaires (Bakhai et
al., 2017). However, use of clinical support tools and alerts should be further explored (Grover et
al., 2016).
Discussion
Summary of Evidence
The articles reviewed provided substantial support for adoption and integration of OSA
screening tools in the primary care setting. Primary care providers are in an important position to
facilitate early screening (Aurora & Quan, 2016). Despite this, lack of sufficient screening
continues to be an issue within primary care (Addogoh, 2018; Bakhai et al., 2017; Khan et al.,
2019; Ononye et al., 2019). While the benefit of implementing screening is recognized, research
is still needed regarding the best strategies for timely identification of patients that have
undiagnosed OSA. Prominent guidelines provide different suggestions regarding screening only
symptomatic individuals or screening high risk. However, it is important to note that none of the
screening guidelines recommend widespread screenings for all primary care patients (Khan et al.,
2019.)

In addition to the variation in professional guidelines, there remain barriers that need to
be overcome in order to improve identification of OSA positive patients. The limitations in the
study pointed to the need for improved healthcare education on OSA impact and available
screening tools, enhancement of EMR capability, along with financial reimbursement for time
spent screening. Furthermore, while the screening tests tend to have high sensitivity, they
consistently provide low specificity for OSA requiring a thorough work up and follow up testing
to make a diagnosis.
Multiple articles noted that use of sleepiness scales, such as the ESS, are not ideal for
identifying high risk OSA patients due to variability in predicting the presence or absence of
sleep apnea (Aurora & Quan, 2016). But this tool continues to be used for initial screening
(Addogoh, 2018; Johnson, 2019). The STOP-Bang was one of the most widely used tools in the
review of literature. The tool is easy to use with eight dichotomous questions in addition to being
consistent with the sensitivity and specificity (Miller & Berger, 2016).
Limitations
The integrative review does have some limitations. Limitations noted within the review
of literature include articles that were not limited to the United States. Additionally, the articles
included in the review predominately consisted of level IV (case control or cohort) studies and
look for correlations. While these studies add to the pool of evidence they are not as strong as
randomized control trials (University of Michigan, 2020). Barriers to OSA screening identified
in the review of literature were predominately noted by interviewing healthcare providers and
could impact the strength of the findings (Bakhai et al., 2017). Some of the successful practices
were tested in the review of literature but there were limitations in testing the impact of

modifying the capability of the electronic medical record. Most studies noted that improvements
within the EMR would likely help but this was not studied in the articles reviewed.
Conclusions
Literature supported the need for increased detection of obstructive sleep apnea. Primary
care clinics are an opportune setting to identify high risk OSA individuals. The integrative
review utilized mixed method articles to identify current screening tools, barriers, as well as
facilitators to increasing OSA screening in the primary care. The screening tools were reviewed
for their utility in the primary care setting and revealed most screening tools to have a high
sensitivity but low specificity. The perceived barriers and recommended facilitators to improve
OSA screening provide suggestions for practice changes and further research. OSA will remain
under detected and undertreated unless action is taken to pursue best methods for detection,
streamline the screening process, and implement strategies for continued improvement.
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Tables
Table 1
Inclusion and Exclusion Criteria
Inclusion Criteria
Publications from 2016-2020
Adult patient population (>18 yrs.)
Peer-reviewed, gray literature (i.e.
unpublished articles, dissertations,
frameworks, policy documents, etc.)
Primary Care
Full-text articles
English language

Exclusion Criteria
Publications during or prior
to 2015
Pediatric patient population (<18 yrs.)
Non-research articles (i.e.
commentaries, editorials, briefings,
fact sheets)
Hospital or Specialty Practice
Abstract only articles
Publications written in a foreign
language
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Table 2
Results Matrix Obstructive Sleep Apnea Screening in Primary Care
Focus of
Article,
Author/year
Comparing neck
grasp and
circumference to
STOP-Bang and
Berlin
questionnaires in
the primary care
population
among type 2
diabetics.
(Edmonds,
Gunasekaran, &
Edmonds, 2019).

Study aimed to
assess OSA risk
using the Berlin
questionnaire and
Epworth
Sleepiness Scale.
Additionally, the
study evaluates
multiple
morbidities to
determine the
epidemiological

Level of
Evidence/Source
IV/Primary

OSA/ Background
§

§

IV/Primary

•

§

Conclusions/ Practice Implications/ Recommendations

Convenient sample Conclusions:
of type 2 diabetics For the diabetic population
from an internal
§ For mild OSA (AHI 5-14) the most sensitive screening test
medicine clinic for
was the STOP-Bang (sensitivity 87.2%)
routine visits
§ For moderate OSA (AHI 15—29) the most sensitive
between 2015screening test was the Berlin
2016.
§ Both Berlin and STOP-Bang were most sensitive for severe
86 participants
OSA (AHI >30)
were screened with
§ Most specific test was neck circumference with specificity of
43 meeting
70.4%.
inclusion criteria
Practice Implications/ Recommendations:
(Type 2 diabetes
§ Relying on neck circumference avoids the subjective
and no prior OSA
questions
dx)
§ A negative neck circumference and ESAP screening does not
rule out OSA due to the low sensitivity
§ Study reinforces the importance of screening OSA in patients
with type 2 diabetes
Conclusions:
Cross-sectional
screening study of
• High pre-test likelihood noted in individuals with history of
490 elderly adults
stroke, diabetes, cardiovascular disease, and mental health
(65+) utilizing
disorders compared to others with no history of chronic
home care services
disease.
in Greece.
• Multiple co-morbidities (2+) showed statistically significance
Data collection
with high OSA likelihood.
between January
• Both the Berlin and ESS had good internal consistency
and June 2010
(Cronbach’s alpha coefficient 0.69 (Berlin) and 0.77 (ESS).
• One third of the studied population was considered high risk.
Practice Implications/ Recommendations:

link for the
elderly
population in the
primary care
(Kleisiaris et al.,
2016)
Study to assess
the rate of prior
screening among
patients prior to
being
hospitalized for
persistent atrial
fibrillation (AF)
and willingness
of patients to
have further
testing among
those identified
as moderate or
high risk (Khan
et al., 2019).

Quality
improvement
study aimed at
increasing the
OSA diagnosis
among patients
with
hypertension in a
primary care
setting (Bakhai,
Nigam, Saeed,

•
•

IV/Primary

•

•

•

Primary/IV

•

•

Total of 254
persistent AF
patients were
surveyed regarding
prior OSA
screening.
STOP-Bang
utilized to identify
of patients not
screened were
moderate or high
risk.
Prior
cardioversions and
willingness for
further testing was
also recorded in
the study
Screened HTN
patients in the
primary care from
July 2015December 2015
using the STOPBang
questionnaire.
1000 convenient
OSA
questionnaires
completed at the

OSA in the older population often occurs along with multiple
common chronic diseases
Recommends systematic screening in the primary care.

Conclusions:
• 66% of AF patients were never screened for OSA.
• Of the population that was not screened 75% were deemed
high risk based on the STOP-Bang.
• Individuals with prior hospitalizations or cardioversions were
more likely to be screened for OSA.
• Among the high-risk group 79% were interested in obtaining
a sleep study.
Practice Implications/ Recommendations:
• Based on the population surveyed the majority of AF patients
are not screened for OSA.
• Study recommends OSA screening for AF patients be a focus
for the primary care.

Conclusions:
• Retrospective review of patients seen at the clinic
demonstrated that only 1% of patients with hypertension were
screened and diagnosed with OSA.
• Goal to increase OSA dx from baseline to 5% among HTN
patients. (Goal not met due to multiple barriers)
• Physician barriers to acceptance included: 1.) lack of EMR
chart alerts 2.) lack of extra time needed to complete
screening questionnaire.
• Patient barriers to obtaining follow up sleep studies: 1.) fear
of sleep study procedure 2.) fear of diagnosis and treatment
3.) cost -due to high co-pay or lack of insurance 4.) lack of

Krishnan, &
Reynolds, 2017).

A review of
literature to
determine if
appropriate
assessment of
OSA at the PCP
is being
conducted
(Aurora & Quan,
2016).

II/Secondary

Determine the
value of STOPBang OSA
screening among
hypertensive
patients in the
primary care
setting

IV/Primary

internal medicine
clinic among HTN
patients.
• 318/1000 patients
screened high risk
using the STOPBang
• Of the 255 patients
with OSA (score
between 3-5) 50%
agreed to a sleep
study referral.
A total of 364 articles
were reviewed that
addressed sleep apnea,
screening, and common
comorbidities.

transportation to sleep study 5.) lack of knowledge regarding
OSA
Practice Implications/ Recommendations:
• Integrate screening tool into the EMR
• Provide OSA brochures for patients.

Conclusion/Practice Implications/
Recommendations:
• After a review of cost-benefit of universal vs high risk patient
population it was determined that screening should be limited
to high risk groups.
• Sleepiness scales are not recommended for identification of
OSA as they are not as specific.
• High risk groups include: “obesity (BMI ≥ 30 kg/m2),
congestive heart failure, atrial fibrillation, treatment resistant
hypertension (blood pressure above goal despite adherence to
antihypertensive regimen of 3 medications, or hypertension
controlled by at least 4 medications), impaired glucose
tolerance or type 2 diabetes, nocturnal dysrhythmias, stroke,
pulmonary hypertension, preoperative for bariatric surgery,
coronary artery disease” (Aurora & Quan, 2016).

A convenient sample of 32 Results/Conclusions:
adult patients with
• Small sample size (N=30)
hypertension taken over a
• 40% (n=12) screened high risk.
three-month period. Two
• Only three patients that screened high risk obtained a sleep
of the patients were then
study.
excluded due to already
• However, all three that obtained the sleep study were
having an OSA dx.
diagnosed with OSA.
Practice Implications/

(Showalter &
OʼKeefe, 2019).

Recommendations:
• Despite the small sample size, the study recommends a
written protocol at the primary care clinic for screening OSA
patients among patients with hypertension based on the
conclusions in the study and prior literature.
• Recommends providing alerts in the EMR for patients that
quality for screening.

Quality
improvement
study of
implementing a
protocol for OSA
screening in the
primary care
setting using the
STOP-Bang
questionnaire
(Ononye,
Nguyen, &
Brewer, 2019).

III/Primary

Review the
current screening
an assessment of
OSA in primary
care as well as
the validity of
OSA
questionnaires in
the primary care

II/Secondary

Convenient sample of 187
patients participated in the
study. Female patients 99
(53%) male patients 88
(47%).

•

A review of
articles published
between 1991 and
2014. A total of 17
articles met the
inclusion and
exclusion criteria.
Non-experimental
(N=14) and

Conclusions:
• Randomized chart audit (60 charts) noted that only 3% (n=2)
of patients were routinely screened for OSA during visits preprotocol.
• Randomized chart audit (60 charts) post-protocol
implementation had an increase to 43% (n=26)
• Referral rates increased after implementing the protocol preprotocol (0%) compared to post-protocol 39% (n=24).
• Primary care physicians do not routinely screen for OSA.
Potential barriers could be: uncertainty with identification
diagnosis, best sleep monitors for OSA diagnosis, and how to
manage patients once diagnosed.
Practice Implications/
Recommendations
• Recommends utilizing a protocol in the primary care setting
to improve detection and referral of patients at high risk for
OSA.
• States that the STOP-Bang has good utility in the primary
care.
Conclusions:
• Consensus that there needs to be a screening tool for OSA in
primary care.
• Data limited on reliability of STOP-bang in the primary care.
• Berlin questionnaire has psychometric properties for the
primary care.
• Epworth sleepiness scale has inconsistent sensitivity/
specificity for OSA.
Practice Implications/

setting (Miller &
Berger, 2016).

The reliability of
STOP-Bang
questionnaire
(Portuguese
version) for the
screening of
OSA within the
primary care in
Portugal
(RebeloMarques,Vicente,
Valentim, &
Agostinho,
2018).
The value of
using oximetry
alone or in
combination with
the Phillips
questionnaire in
predicting OSA
within the
primary care
(Fabius,
Benistant,
Pleijhuis, Van, &
Eijsvogel, 2019).

IV/Primary

IV/Primary

experimental
(N=3)
• Review was
limited to the
STOP, STOPBang, Epworth
sleepiness scale,
and Berlin
questionnaire.
A convenient sample over
8 months of two hundred
fifty-nine patients (aged
18 and older) that
completed the STOP-Bang
at a single primary care

Recommendations
• Supports the need for a standardized screening tool.
• Suggests that the Berlin questionnaire may prove more
beneficial in the primary care, but more studies are needed.

A total of 140 subjects
with suspected OSA were
include in the study from
54 primary care practices.

Conclusions:
• OSA was diagnosed in 71% of the subjects. The oxygen
desaturation index (ODI) (greater or equal to 5) had a
sensitivity of 99% and specificity of 50%. When combined
with the questionnaire sensitivity was 100% with specificity
of 35%.
Practice Implications/
Recommendations
• Supports that the oximetry alone or in combination is helpful
to exclude OSA diagnosis due to high sensitivity.

Conclusions:
• Suggests that the STOP-Bang is a beneficial tool in other
populations outside of the U.S given the high sensitivity.
Practice Implications/
Recommendations
• Other tests should be used to confirm due to the low
specificity.

•

Identify the
benefit of sleep
apnea screening
questionnaires
(STOP-Bang,
OSA-50, Berlin)
alone and in
combination with
the Epworth
sleepiness scale
(ESS) within the
primary care
setting
(Senaratna,
2019).

IV/Primary

Determine the
ability of the
SACS tool to
accurately detect
OSA in the
primary care
setting (Grover,
Mookadam,
Chang, & Parish,
2016).

IV/Primary

•

Providing STOPBang OSA
questionnaire
training to
primary care

IV/Primary

•

•

•

Performed within
the Tasmanian
Longitudinal
Health Study
(TAHS), 6th
Decade Follow‐up
Random sample of
772 participants
were invited to
participate in the
study.
424 patients
participated in the
study by
completing
questionnaires and
home-based sleep
studies.
191 patients were
included in the
study. After
completing the
SACS participants
completed an
overnight
oximetry, sleep
medicine
consultation and
polysomnography.

Education for
STOP-Bang
provided to 15
primary care

Conclusions:
• Sensitivity/specificity of STOP-Bang alone (81% and 36%
respectively) Sensitivity/specificity of STOP-Bang with ESS
(50% and 92%)
Practice Implications/
Recommendations
• The screening tools together with an ESS >8 are beneficial in
ruling in but not ruling out clinically significant OSA.
• The Stop-Bang/ESS may be a useful tool in the primary care
for referrals.

Conclusions:
• With OSA defined as AHI≥ 10 a SACS score greater than 15
was 40% sensitive and 90% specific for OSA
Practice Implications/
Recommendations
• Due to the findings, the study suggest that the SACS
screening tool is helpful in determining individuals at risk for
OSA in the primary care setting.
• Recommends further studies to determine best practices to
facilitate use.
• Suggests that clinical alerts and clinical decision support tools
could prove beneficial in facilitating use and should be
explored.
Conclusions:
• Large increase in sleep study referrals for all primary care
providers post implementation of the STOP-Bang.
Practice Implication/ Recommendations

providers to
improve sleep
study referrals
(Addogoh,
2018).

Integrating an
Epworth
Sleepiness Scale
clinical advisor
into the EMR to
improve OSA
screening
(Johnson, 2019).

•

III/Primary

•

•

providers at six
• Recommends from the study include integrating the STOPdifferent locations.
Bang into the EMR and establishing a screening protocol.
STOP-Bang
questionnaire
utilized for three
months on patients
over the age of 18
being seen during
wellness exams.
Conclusions:
Patients were
selected by
• Imbedding the ESS in the EMR for screening of all internal
reviewing the
medicine patients resulted in a 20% detection in high risk
EMR and
OSA patients.
including every
Practice Implication/ Recommendations
fifth patient during
• Integrating the ESS into the EMR can help to identify
the designated time
patients at risk that remain undiagnosed.
frame. A total of
• Recommends not only placing the ESS in the EMR but also
50 patients
including hard stops that require providers to screen every
selected from each
patient.
6-week period to
equal 150. The
sample consisted
of 150 men and
women ages 18-92
at an internal
medicine office
with two
providers.
Chart reviews
conducted for pre
ESS for 6 weeks, 6
weeks ESS
learning phase, and
6 weeks post
implementation.

Identifying the
knowledge and
attitudes of
primary care
providers in
Malaysia with
regards to
obstructive sleep
apnea utilizing
the OSAKA
questionnaire
(Devaraj, 2020)

VI/Primary

•

•

•

•

A convenient
sample of 207
primary care
physicians,
employed at a
clinic in Kuala
Lumpur Malaysia,
were surveyed
utilizing the
OSAKA
questionnaire.
Cross sectional
study was
completed over a
3-month period
during 2017.
Knowledge
domain of the
questionnaire asks
18 questions.
Attitude domain
asks 5 Likert scale
questions.

Conclusions:
• Mean score for knowledge was 11.6 The OSAKA has a total
maximum score of 18 for the knowledge domain. (mean score
=65%)
• More than 55% scored above the mean knowledge score.
• The mean score for the attitude domain was 15.9. The
OSAKA has a total maximum score of 24 for the attitude
domain.
• There was no single item that was answered correctly or
incorrectly by all participants.
• Findings from the study were consistent with previous studies
done in other countries as it demonstrated similar knowledge
and attitude scores.
• Most of the primary care physicians that were screened do not
utilize OSA screening tools.
Practice Implication/ Recommendations
• Recommends additional education on OSA for the primary
care providers to improve overall knowledge and
management of the condition.
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